Nav: Home

Breaking open the gates of antibiotic resistance

April 30, 2019

PHILADELPHIA - Antibiotic resistance is a major health threat, with about two million people in the US getting an antibiotic-resistant infection per year, according to the Centers for Disease Control and Prevention (CDC). Gram negative bacteria, including types like E.coli and Salmonella, are often more difficult to kill because of their two-pronged defenses - they have two membranes rather than one, and also have numerous toxin pumps embedded in the membranes to expel any antibiotic that may have made it through. Now Jefferson researchers have uncovered how to target both of these defenses with one hit, which could help make antibiotics more effective.

"We showed that interfering with a transfer RNA (tRNA) molecule, in a way that is unique to bacteria, cripples the bacterial cell's ability to make membrane proteins required for the drug barrier and efflux activity," says senior author Ya-Ming Hou, PhD, Professor of Biochemistry at the Sidney Kimmel Medical College at Jefferson (Philadelphia University + Thomas Jefferson University). The work was published in the journal Cell Systems.

tRNA molecules are not a typical antibiotic target. These molecules are part of the protein-building machinery that is essential for the daily function of cells in every living being. However, Dr. Hou's team examined a kind of chemical "decoration" process in bacterial tRNAs that is absent from human cells. This difference between bacteria and humans makes this process a better drug target, since it's less likely affect human cells.

tRNAs are decorated with chemical groups that are added on after tRNAs are synthesized in a cell. Dr. Hou's group examined one such decoration, the addition of a methyl group to one particular location on the spine of several tRNAs. In earlier work, Dr. Hou's lab showed that when these tRNAs were deficient in this one methylation, they were more likely to create errors in protein building. But not just any protein, the deficient tRNAs were particularly prone to mistakes at building proteins that sit within cell membrane.

This result made Dr. Hou think that perhaps a defect in the tRNA methylation might affect not only the bacteria's toxin-pump, but a host of other types of proteins that help keep the membrane stable and cohesive.

In this paper, together with first author postdoctoral fellow Isao Masuda and others, Dr. Hou tested whether these defective tRNAs could make bacteria more susceptible to antibiotics, by creating bacteria that are genetically deficient in making the methyl-group decoration.

Through an elegant series of experiments, Dr. Hou's team showed that these bacteria had membranes that were less cohesive and more permeable than normal. The bacteria with defective tRNAs were less effective at pumping out chemicals relative to the normal bacteria, suggesting that their toxin pumps were affected. Finally the team showed that when the bacteria with defective tRNAs were exposed to various antibiotics, they died faster and were also less capable of developing drug resistance.

"Speed of killing is important in antibiotics," says Dr. Hou. "The longer it takes for bacteria to die from antibiotics, the more likely they are to develop resistance."

While pharmaceutical companies such as AstraZeneca and GSK have discovered compounds that can inhibit the enzyme from making the critical methylation on tRNAs, progress has stalled. The primary reason is that the inhibitors are unable to permeate through the bacterial membrane structure, which resonates with the major challenge confronting the entire field of antibiotic discovery.

Dr. Hou acknowledges the challenge. "First, we need to formulate the inhibitors in such a way as to be able to enter the cell more effectively," says Dr. Hou. "Then, combining these inhibitors with traditional antibiotics to kill bacteria faster and reduce the likelihood of antibiotic resistance."

At the moment, there are no drugs that can effectively attack this pathway. Dr. Hou's lab is currently working on developing better inhibitors.
The study was funded by grants from the US National Institutes of Health (GM108972, GM114343 and GM080279) and the National Science Foundation (DMR-1120901 and MCB-1149328), the Allen Discovery Center at Stanford on Systems Modeling of Infection (to KCH), the Canadian Institutes of Health Research (CIHR MOP-77688), a JSPS postdoctoral fellowship and the Chan Zuckerberg Biohub.

Article Reference: Isao Masuda, Ryuma Matsubara, Thomas Christian, Enrique R. Rojas, Srujana S. Yadavalli, Lisheng Zhang, Mark Goulian, Leonard Foster, Kerwyn Casey Huang and Ya-Ming Hou, "tRNA Methylation Is a Global Determinant of Bacterial Multi-Drug Resistance," Cell Systems,DOI: 10.1016/j.cels.2019.03.008, 2019.

Media Contact: Edyta Zielinska, 215-955-7359,

Thomas Jefferson University

Related Bacteria Articles:

Bacteria must be 'stressed out' to divide
Bacterial cell division is controlled by both enzymatic activity and mechanical forces, which work together to control its timing and location, a new study from EPFL finds.
How bees live with bacteria
More than 90 percent of all bee species are not organized in colonies, but fight their way through life alone.
The bacteria building your baby
Australian researchers have laid to rest a longstanding controversy: is the womb sterile?
Detecting bacteria in space
A new genomic approach provides a glimpse into the diverse bacterial ecosystem on the International Space Station.
Hopping bacteria
Scientists have long known that key models of bacterial movement in real-world conditions are flawed.
Bacteria uses viral weapon against other bacteria
Bacterial cells use both a virus -- traditionally thought to be an enemy -- and a prehistoric viral protein to kill other bacteria that competes with it for food according to an international team of researchers who believe this has potential implications for future infectious disease treatment.
Drug diversity in bacteria
Bacteria produce a cocktail of various bioactive natural products in order to survive in hostile environments with competing (micro)organisms.
Bacteria walk (a bit) like we do
EPFL biophysicists have been able to directly study the way bacteria move on surfaces, revealing a molecular machinery reminiscent of motor reflexes.
Using bacteria to create a water filter that kills bacteria
Engineers have created a bacteria-filtering membrane using graphene oxide and bacterial nanocellulose.
Probiotics are not always 'good bacteria'
Researchers from the Cockrell School of Engineering were able to shed light on a part of the human body - the digestive system -- where many questions remain unanswered.
More Bacteria News and Bacteria Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab